From 2005 to 2026, Hainan Huayan Collagen Technology Co., Ltd. (hereinafter referred to as Hainan Huayan) has travelled a journey of 21 years. These two decades and one year mark an arduous journey where a dream seed for biological health took root in Hainan and sprouted into vigorous growth. It constitutes an epic of endeavour witnessing the steady advancement and iterative upgrading of China’s collagen peptide industry. Above all, it is a heartwarming journey of sincere companionship and mutual commitment shared with countless global partners. Standing at this new historical milestone of our 21st anniversary, we harvest fruitful achievements from past years and set sail for a brand-new journey ahead.

Reviewing our 21 years of intensive cultivation and accumulation, we have tempered our core competitiveness and sorted through our developmental gains across multiple dimensions including production capacity, product portfolio, brand building, research & development (R&D), and quality management. Riding the developmental momentum of Hainan Free Trade Port (Hainan FTP), we draw up a new blueprint for global expansion. Guided by our original aspiration, we forge ahead fearlessly; driven by innovation, we march toward the world to unveil a brand-new chapter of high-quality corporate development.

Over 21 years of steady progress, bolstered by solid technical barriers, a comprehensive industrial layout and promising industry prospects, Hainan Huayan has won consistent recognition and favour from the capital market. In March 2026, the company completed a landmark strategic financing round, securing strategic cooperation with a roster of high-quality capital institutions including Huaxi YuYou Fund, Langhan Nonghui Emerging Industry Fund and Wenrun Investment.

The participation of these multiple top-tier capital partners not only represents the capital market’s high recognition of our technical prowess, industrial value and growth potential forged through two decades of dedicated research in marine biological peptides, but also infuses the enterprise with core driving forces covering capital support, industrial resources and channel deployment. This momentum propels Hainan Huayan to accelerate its pace toward the capital market and step into a new phase of high-quality globalised development.

Throughout its 21 years of industrial cultivation, while consolidating strengths in production capacity, technology and products, Hainan Huayan keeps expanding its developmental boundaries by actively boosting government-enterprise coordination and collaboration with well-known enterprises, thereby building multi-level and diversified industrial cooperation platforms. Leveraging the geographical and policy dividends of Hainan Free Trade Port, the company takes an active part in local industrial construction and establishes in-depth strategic partnerships with central state-owned enterprises and leading private enterprises. Supported by premium peptide raw materials and innovative R&D capabilities, we facilitate brand upgrading and industrial advancement. Thanks to outstanding cooperation outcomes and reputable industry performance, we have been frequently covered by major mainstream media, steadily elevating our brand credibility, industrial influence and market reputation.

Government-enterprise coordination fuels regional growth, while brand collaboration vitalises industrial dynamics. As a local science and innovation enterprise rooted in Hainan, Hainan Huayan earnestly fulfils its corporate social responsibility and responds proactively to the national call for Hainan FTP development. As a representative local enterprise, we participate deeply in the organisation and promotion of the Hainan FTP Import and Export Expo, showcasing the achievements of Hainan’s biological peptide sector and the technological strength of Chinese domestic innovations to the world, helping the high-end health industry of the Free Trade Port gain greater international exposure and recognition.

In terms of corporate strategic cooperation, we continuously advance symbiotic collaboration with leading brands and have delivered multiple landmark cooperative projects. We entered into an in-depth strategic partnership with COFCO Food Technology. Drawing on our self-developed premium plant peptides and functional peptide raw materials, we delve into the national public health sector and upgrade domestic healthy food products with natural, safe and high-activity peptide ingredients. We also rolled out an innovative co-branded project with a coffee brand under Want Want Group, building immersive offline experience venues. This initiative breaks the traditional cooperation boundaries of raw material manufacturers. With scenario-based and youth-oriented brand operations, we realise industrial empowerment and brand breakthrough, injecting fresh vitality into the end consumer market.

These innovative practices in government-enterprise linkage and brand synergy have diversified Hainan Huayan’s industrial layout and optimised our brand ecosystem. Backed by robust scientific research strength, abundant cooperative resources and a stable global production system, our products are sold to more than 50 countries and regions including Japan, South Korea, the United States, Thailand, Singapore, Indonesia and Malaysia. We deliver comprehensive empowerment to global partners and build a win-win global industrial cooperation ecosystem featuring government-enterprise coordination and interconnected brands.

During 21 years of persistent dedication, Hainan Huayan has consistently focused on the full industrial chain development of biological peptides, continuously optimising production base layout and upgrading production capacity. Supported by large-scale, intelligent and eco-friendly manufacturing capabilities, we consolidate a stable foundation for global supply chains. As a pivotal year for leaps in production capacity, the company has completed multiple capacity upgrades and new base deployments, fully unlocking our accumulated industrial strengths and expanding our global production footprint for a more sophisticated industrial layout.

To date, we have established six global manufacturing bases in Hainan Headquarters (Haikou), Wenchang (Hainan), Zhoukou (Henan), Liaocheng (Shandong) and Bangkok (Thailand). Meanwhile, five domestic sales and operation centres have been set up in Haikou, Guangzhou, Zhengzhou, Chengdu and Hangzhou. Our controllable annual production capacity has exceeded 10,000 tonnes, forming an integrated industrial matrix covering R&D, production and sales of biological peptides with global reach and efficient collaboration, delivering reliable capacity assurance for clients worldwide.

Each production base is equipped with a modern brand exhibition hall, featuring tidy and standardised production workshops, pleasant ecological surroundings and complete supporting hardware and software facilities. To enhance transparency in cooperation and customer experience, all production bases are open to partners for on-site exhibition hall tours, factory inspections and full-process traceability verifications. Through visualised and transparent displays of standardised production workflows, rigorous quality control systems and eco-friendly smart manufacturing capabilities, we solidify trust-based cooperation and strengthen bonds with partners at home and abroad.

Since its foundation, guided by actual market demands, Hainan Huayan has focused on the biological peptide track, enriching our product portfolio and optimising production techniques. Our offering has evolved from a single type of raw material into a comprehensive, scenario-oriented and differentiated product system that accurately caters to diversified demands from global end markets.

After 21 years of development, our product system has matured extensively. Starting with fish peptide raw materials, we have expanded our portfolio into aquatic peptides, terrestrial animal peptides and plant peptides, with over 100 product variants available to satisfy raw material application requirements across various industries and scenarios. In parallel, we keep refining production technologies to manufacture peptides featuring higher activity, finer granularity and stronger functional properties.

Keeping pace with prevailing innovation trends in downstream industries, we have ramped up R&D and launch of new products. This year, we have launched two innovative raw materials: tuna bone powder (formulated for liquid calcium products) and small-molecule collagen peptides (tailored for protein water). These new materials precisely target high-growth segmented tracks including health beverages and nutritional calcium supplements. Our scenario-specific and differentiated new product solutions respond to emerging market trends, spearhead development in niche markets, fuel application innovation for end products across the industry, and supply partners with more competitive product solutions.

Scientific and technological innovation stands as the core driving force for sustainable corporate development. For 21 years, Hainan Huayan has adhered to independent innovation, conducted in-depth research on cutting-edge biological peptide technologies, built high-end scientific research platforms and recruited top-tier research talent. We have established a closed-loop innovation system covering scientific research, talent cultivation and achievement commercialisation to continuously reinforce our core R&D competence.

Supported by three core innovation platforms – a Postdoctoral Research Workstation, Hainan Provincial Engineering & Technology Research Center for Biological Peptides and industry-university-research joint laboratories – we carry out targeted technological breakthroughs in advanced biological peptide fields. Increased R&D investment and recruitment of high-calibre research teams provide solid backing for technological innovation and product iteration.

Over the past year, the company has achieved fruitful scientific research outcomes; mass production technologies for multiple novel functional peptides have been successfully translated into commercial output, lifting the overall technical standard of China’s small-molecule peptide industry and driving industrial upgrading. Our outstanding R&D strengths have been recognised with numerous authoritative accolades, including National High-tech Enterprise, National Intellectual Property Advantage Enterprise, High-tech Gazelle Enterprise, Specialised, Refined, Unique & Innovative Enterprise, and the First Prize of Hainan Provincial Technical Invention Award. We have also been selected as a pilot entity for the National Intellectual Property Demonstration Project, marking that our capabilities in intellectual property creation, utilisation, protection and administration have reached a new national benchmark level.

The company owns more than 120 patents both domestically and internationally, has published four independent research papers in SCI-indexed international journals, and participated in drafting four national standards and two industrial standards for collagen peptides, fully demonstrating our technological leadership and participation in formulating industrial norms.

Stringent quality management has remained an unwavering operational principle for Hainan Huayan over the past 21 years. Aligning with the world’s most stringent quality benchmarks, we have built a full-process, standardised and traceable quality management system that monitors every link from raw material procurement and manufacturing to finished goods delivery, ensuring consistently high-quality product output.

Our entire production chain has obtained a full suite of authoritative certifications including US FDA Registration, cGMP, ISO22000, ISO9001, ISO14001, HACCP, FSSC22000 and MSC, alongside international compliance certificates such as Kosher, HALAL and MUI, fully complying with market access regulations across major global markets. Our products are free of pesticide and antibiotic residues, featuring core merits including small molecular weight, high biological activity, high protein content and low fat content, meeting strict quality requirements of high-end markets in the EU, Japan, North America and other regions. We have set a benchmark for premium domestic peptide raw materials through rigorous quality control systems.

The 21st anniversary marks a milestone of solid progress for Hainan Huayan, as well as a new starting point for pursuing greater aspirations. The biological peptide industry is now witnessing a golden window of explosive growth, with new productive forces serving as the core engine for high-quality industrial development. Riding the strategic opportunities brought by Hainan Free Trade Port, the company commits to high-quality, globalised and innovation-driven development to map out its future growth trajectory.

Staying true to our original aspiration enables long-distance progress; united strength empowers us to traverse mountains and seas. Every milestone achieved by Hainan Huayan over these 21 years would not have been possible without the trust and companionship of our global partners, joint efforts from industry peers, as well as policy support from governments at all levels and research institutions. Moving forward, we will uphold our commitment to product quality and persist in technological innovation. With stable production capacity, cutting-edge technologies, professional services and an open mindset, we will take root in Hainan while facing the whole world. Hand in hand with all partners, we will write a magnificent new chapter for the high-quality development of China’s biological peptide industry.